Page last updated: 2024-09-03

ro 32-0432 and serine

ro 32-0432 has been researched along with serine in 1 studies

Compound Research Comparison

Studies
(ro 32-0432)
Trials
(ro 32-0432)
Recent Studies (post-2010)
(ro 32-0432)
Studies
(serine)
Trials
(serine)
Recent Studies (post-2010) (serine)
5601323,9141156,084

Protein Interaction Comparison

ProteinTaxonomyro 32-0432 (IC50)serine (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.015
CholinesteraseEquus caballus (horse)0.016

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayuzawa, R; Doi, C; Kawabata, A; Matsuzuka, T; Nguyen, TA; Pickel, L; Reischman, J; Seiler, G; Tamura, M1

Other Studies

1 other study(ies) available for ro 32-0432 and serine

ArticleYear
C1B domain peptide of protein kinase Cγ significantly suppresses growth of human colon cancer cells in vitro and in an in vivo mouse xenograft model through induction of cell cycle arrest and apoptosis.
    Cancer biology & therapy, 2012, Volume: 13, Issue:10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Female; Humans; Indoles; Injections, Intralesional; Isoenzymes; Mice; Mice, SCID; Peptide Fragments; Peptides; Phosphorylation; Protein Interaction Domains and Motifs; Protein Kinase C; Pyrroles; Serine; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2012